| Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response G Chen, AC Huang, W Zhang, G Zhang, M Wu, W Xu, Z Yu, J Yang, ... Nature 560 (7718), 382-386, 2018 | 2157 | 2018 |
| Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ... Science 369 (6508), eabc8511, 2020 | 1570 | 2020 |
| T-cell invigoration to tumour burden ratio associated with anti-PD-1 response AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ... Nature 545 (7652), 60-65, 2017 | 1499 | 2017 |
| Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia JA Fraietta, SF Lacey, EJ Orlando, I Pruteanu-Malinici, M Gohil, S Lundh, ... Nature medicine 24 (5), 563-571, 2018 | 1396 | 2018 |
| TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion O Khan, JR Giles, S McDonald, S Manne, SF Ngiow, KP Patel, MT Werner, ... Nature 571 (7764), 211-218, 2019 | 1149 | 2019 |
| Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade KE Pauken, MA Sammons, PM Odorizzi, S Manne, J Godec, O Khan, ... Science 354 (6316), 1160-1165, 2016 | 1139 | 2016 |
| Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade JL Benci, B Xu, Y Qiu, TJ Wu, H Dada, C Twyman-Saint Victor, L Cucolo, ... Cell 167 (6), 1540-1554. e12, 2016 | 1042 | 2016 |
| Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms JC Beltra, S Manne, MS Abdel-Hakeem, M Kurachi, JR Giles, Z Chen, ... Immunity 52 (5), 825-841. e8, 2020 | 619 | 2020 |
| A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ... Nature medicine 25 (3), 454-461, 2019 | 579 | 2019 |
| TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision Z Chen, Z Ji, SF Ngiow, S Manne, Z Cai, AC Huang, J Johnson, ... Immunity 51 (5), 840-855. e5, 2019 | 516 | 2019 |
| CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, ... Nature medicine 27 (7), 1280-1289, 2021 | 426 | 2021 |
| Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC) AM Menzies, RN Amaria, EA Rozeman, AC Huang, MT Tetzlaff, ... Nature medicine 27 (2), 301-309, 2021 | 326 | 2021 |
| Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells B Bengsch, T Ohtani, O Khan, M Setty, S Manne, S O’Brien, PF Gherardini, ... Immunity 48 (5), 1029-1045. e5, 2018 | 284 | 2018 |
| A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance AC Huang, R Zappasodi Nature immunology 23 (5), 660-670, 2022 | 259 | 2022 |
| Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial BS Abella, EL Jolkovsky, BT Biney, JE Uspal, MC Hyman, I Frank, ... JAMA internal medicine 181 (2), 195-202, 2021 | 215 | 2021 |
| Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19 LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, ... Science immunology 6 (57), eabf7570, 2021 | 205 | 2021 |
| IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity BM Carreno, M Becker-Hapak, A Huang, M Chan, A Alyasiry, WR Lie, ... The Journal of clinical investigation 123 (8), 3383-3394, 2013 | 181 | 2013 |
| Non-conventional inhibitory CD4+ Foxp3− PD-1hi T cells as a biomarker of immune checkpoint blockade activity R Zappasodi, S Budhu, MD Hellmann, MA Postow, Y Senbabaoglu, ... Cancer cell 33 (6), 1017-1032. e7, 2018 | 158 | 2018 |
| Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy R Somasundaram, T Connelly, R Choi, H Choi, A Samarkina, L Li, ... Nature communications 12 (1), 346, 2021 | 127 | 2021 |
| UPenn COVID Processing Unit, MR Betts, NJ Meyer, EJ Wherry, Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ... Science 369 (6508), 2020 | 107 | 2020 |
